Evidence map›Paper›PMID 33221042›Full record

ArticleMolecular immunology2021

Enhanced RIPK3 kinase activity-dependent lytic cell death in M1 but not M2 macrophages.

Qin Hao, Suman Kundu, Joshua Kleam, Zhizhuang Joe Zhao, Steven Idell, Hua Tang

Open access · greenAbstract read
In one paragraph

Article in Molecular immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Acute lung injury: a view from the perspective of necroptosis.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2024
    Review
  7. Article
  8. Frontiers in cellular and infection microbiology · 2024
    Article
  9. Review
  10. Article
  11. Article
  12. Intracellular behavior ofFrontiers in cellular and infection microbiology · 2023
    Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. M1 Macrophages Are More Susceptible to Necroptosis.Journal of cellular immunology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Qin HaoDepartment of Cellular and Molecular Biology, The University of Texas Health Science Center at Tyler, Tyler, TX, USA.
Suman KunduDepartment of Cellular and Molecular Biology, The University of Texas Health Science Center at Tyler, Tyler, TX, USA.
Joshua KleamDepartment of Cellular and Molecular Biology, The University of Texas Health Science Center at Tyler, Tyler, TX, USA.
Zhizhuang Joe ZhaoDepartment of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Steven IdellDepartment of Cellular and Molecular Biology, The University of Texas Health Science Center at Tyler, Tyler, TX, USA; Texas Lung Injury Institute, The University of Texas Health Science Center at Tyler, Tyler, TX, USA.
Hua TangDepartment of Cellular and Molecular Biology, The University of Texas Health Science Center at Tyler, Tyler, TX, USA. Electronic address: hua.tang@uthct.edu.
The University of Texas Health Science Center at Tyler · USUniversity of Oklahoma Health Sciences Center · US

Funding

Identification of Novel Necroptosis Pathways in Human Lung Epithelial CellsR21AI135569 · NIAID · UNIVERSITY OF TEXAS HLTH CTR AT TYLER · PI TANG, HUA · 2018 to 2019
$390k
NIAID NIH HHS R21 AI135569
6 · The paper itself

Abstract

Macrophages play a crucial role in host innate immune defense against infection and tissue injury. Macrophages are highly plastic cells and their subtypes have been characterized as M1 (also termed classically activated) and M2 (alternatively activated). Although the M1/M2 paradigm has been well documented, less is known regarding the role of macrophage activation/polarization in inflammation-associated necrotic cell death. To address this gap in current knowledge, we prepared bone marrow-derived macrophages, induced them to M1 or M2 subtypes, and then investigated the expression of necroptosis signaling molecules and macrophage subtype-dependent responses to different necroptosis inducers. We found that necroptosis effector mixed lineage kinase domain-like protein (MLKL) and the key necroptosis regulator Z-DNA/RNA binding protein 1 were predominantly induced in M1 but not M2 macrophages. Interestingly, the protein but not mRNA levels of receptor-interacting protein kinase-3 (RIPK3) were also upregulated in M1 macrophages. We further found that macrophage necrotic cell death, the releases of lactate dehydrogenase and dead cell proteases as well as MLKL phosphorylation at Ser345 in response to various necroptosis inducers were greatly augmented in M1 but not M2 macrophages, and the accelerated effects were blocked by two structurally distinct specific RIPK3 inhibitors GSK872 or GSK843. Thus, our findings demonstrate that M1 but not M2 subtypes of macrophages are more susceptible to inflammation-related lytic cell death in an RIPK3 kinase activity-dependent manner.

Indexed as

AnimalsBenzothiazolesCell DeathCells, CulturedDNA, Z-FormInflammationL-Lactate DehydrogenaseMacrophage ActivationMacrophagesMiceMice, Inbred C57BLNecroptosisPhosphorylationProtein KinasesQuinolinesRAW 264.7 CellsBenzothiazolesDNA, Z-FormGSK872L-Lactate DehydrogenaseProtein KinasesQuinolinesReceptor-Interacting Protein Serine-Threonine KinasesRipk3 protein, mouseRNA-Binding ProteinsRNA, MessengerInflammationM1/M2 paradigmMacrophageMLKLNecroptosisRIPK3

Identifiers

PMID33221042
PMCPMC7750277
OpenAlexW3099462403

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.